Closely monitoring a patient diagnosed with prostate cancer prior to some future possible treatment. Similar to “watchful waiting,” monitoring typically involves annual biopsies and quarterly PSA blood tests. Treatment is undertaken when the biopsy results worsen, PSA rises or the patient decides he wants to pursue treatment.